Skip to main content

Military Health System

Air Force invention kills toxins on contact

Image of a man in a white coat doing experiments. Click to open a larger version of the image. The Air Force is licensing patent rights to a disease-control coating additive to a private-sector company who wants to put the formula in paint and other products. The formula was invented by Dr. Jeff Owens, a senior chemist with the Air Force Civil Engineer Center. Owens developed the technology in collaboration with the Army — collaborative research and development funded by the Defense Threat Reduction Agency, Joint Science and Technology Office under the Chemical and Biological Defense program.

Recommended Content:

Public Health | Coronavirus & the MHS Response | Health and Housing | Mold

An Air Force invention could be key to reducing the amount of airborne microbes - like viruses, bacteria and mold spores - inside buildings and homes.

In 2009, the U.S. Air Force submitted a patent application for an invention that coats surfaces with a protective finish, killing toxins on contact.

The technology, which was granted a patent in 2013, was invented by Dr. Jeff Owens, a senior chemist with the Air Force Civil Engineer Center at Tyndall Air Force Base in Florida, to support his work in chemical and biological warfare defense. 

Today, the Air Force is licensing the rights to that technology to a private-sector company that wants to use Owens’ patented formula in paints and other products.

“The patented technology is essentially an additive that can be incorporated into coatings for surfaces and textiles to protect against bioaerosols like viruses, bacteria and mold,” Owens said.

Under a Cooperative Research and Development Agreement, Florida-based Theriax is collaborating with members of the Civil Engineer Laboratory at Tyndall to develop next-generation coatings that deactivate biological and chemical weapons for the Air Force. This CRADA will also allow the company to bring this technology to the commercial paint market.

The partnership provides a mutually beneficial opportunity for the company to develop a commercial paint product that the Air Force could one day use to improve quality of life and health for Airmen and their families on base, Owens said.

Mold growth is a regular challenge for coastal installations, but after the destruction of Hurricane Michael in October 2018, the CE Lab, like many base buildings that remained intact, required hefty cleanup and a fresh coat of paint. Salter said the research team used the antimicrobial paint on one wall.

The wall remained mold free for six months before the paint needed a recharge, however, over time the disinfectant charge wears off and the paint needs to be recharged by wiping down the treated surface with a disinfectant. The recharge frequency is largely dependent on the environmental conditions.

The partnership that began before Hurricane Michael is now focused on how its research can help in the fight against COVID-19.

While Owens and the other AFCEC scientists remain focused on mission applications of the technology, Owens acknowledged that commercially available products, like paint, would indirectly support the Air Force mission.

“If COVID-19 has taught us anything, it’s that reducing exposure pathways and lowering the concentration of infectious aerosols inside a room is critical to controlling disease spread,” Owens said. “This paint isn’t a magic bullet, but it could be one tool that helps makes a difference in the fight to protect human health.”

You also may be interested in...

NAMI Recompression Chamber Supports Area Training Missions, Operations

Article Around MHS
8/29/2022
Military personnel demos compression chamber

Scuba diving can be extremely dangerous, and it’s possible for divers to develop adverse medical conditions and injuries while performing underwater operations. A common diving injury is decompression sickness (DCS), also referred to as the “bends”.

Recommended Content:

Public Health

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

COVID-19 Moderna and Pfizer Vaccines

Publication
8/17/2022

Moderna and Pfizer mRNA vaccines are available. Moderna includes two doses, 28 days apart. Pfizer includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Moderna Vaccine

Publication
8/17/2022

Moderna and mRNA vaccines are available. Moderna includes two doses, 28 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

COVID-19 Pfizer Vaccine

Publication
8/17/2022

Pfizer mRNA vaccines are available. Pfizer includes two doses, 21 days apart.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | Types of COVID-19 Vaccines | Coronavirus & the MHS Response

Taking the stings out of summer fun

Article
8/15/2022
Beekeeper in protective gear holds framework with bees and honey..

What you should know and do about bee, wasp, and hornet stings

Recommended Content:

Bug-Borne Illnesses | Summer Safety | Public Health

Learn the Most Recent Age Requirements for COVID-19 Vaccines and Boosters

Article
8/10/2022
A man fist bumps a child.

The best way to prevent the spread of COVID-19 is to get your vaccines and booster shots.

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Telemedicine Privilege by Proxy Expands Access to MHS Care

Article
8/10/2022
Infographic featuring Lt Col Legault

MHS has Telemedicine Privilege by Proxy: A fast, efficient process that enables providers to file one application and get permission to virtually treat patients anywhere in the MHS.

Recommended Content:

Coronavirus & the MHS Response | Telehealth Program

What You Need to Know About Monkeypox

Article
8/5/2022
A human hand with sores

Monkeypox is rare. Here’s how to protect yourself and your family and when to contact a medical provider.

Recommended Content:

Monkeypox | Public Health

Monkeypox Declared Public Health Emergency: What Airmen and Guardians Need to Know

Article Around MHS
8/4/2022
Microscopic view of monkeypox virus

The World Health Organization declared monkeypox a public health emergency on July 23. With more than 4,000 cases in the United States, Airmen and Guardians should know the risks and how to stay safe.

Recommended Content:

Monkeypox | Public Health

Whole Health System Approach to Long COVID

Publication
8/1/2022

The U.S. Department of Veterans Affairs Veterans Health Administration is leading an effort to equip health care providers with a Veteran-centered Whole Health System approach to caring for Veterans with Long COVID, also known as post-COVID-19 conditions.

Recommended Content:

COVID-19 Information for Military Treatment Facility Directors | Coronavirus & the MHS Response | Coronavirus

Army Experts: Rabies Risk is Not Worth It

Article
7/5/2022
Army Experts: Rabies Risk is Not Worth It

Almost 60,000 people around the world die from rabies each year. Despite the common belief that rabid animals are easily identified by foaming at the mouth and aggressive behavior, infected animals may not look sick or act strangely.

Recommended Content:

Health Readiness & Combat Support | Public Health | Rabies

MSMR Vol. 29 No. 07 - July 2022

Report
7/1/2022

A monthly publication of the Armed Forces Health Surveillance Division. This issue of the peer-reviewed journal contains the following articles: Surveillance trends for SARS-CoV-2 and other respiratory pathogens among U.S. Military Health System Beneficiaries, Sept. 27, 2020 – Oct. 2,2021; Establishment of SARS-CoV-2 genomic surveillance within the MHS during March 1 – Dec. 31 2020; Suicide behavior among heterosexual, lesbian/gay, and bisexual active component service members in the U.S. Armed Forces; Brief report: Phase I results using the Virtual Pooled Registry Cancer Linkage system (VPR-CLS) for military cancer surveillance.

Recommended Content:

Health Readiness & Combat Support | Public Health | Medical Surveillance Monthly Report

Four-legged Major Brings Joy to Brooke Army Medical Center

Article Around MHS
6/23/2022
Labrador facility dogs at ceremony

Brooke Army Medical Center commissioned a new, four-legged staff member with a penchant for spreading joy to the rank of United States Army major during a ceremony June 6.

Recommended Content:

Health Readiness & Combat Support | Public Health

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 50
Refine your search
Last Updated: August 15, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery